The Effect of Cyclosporine on the Use of Hospital Resources for Kidney Transplantation

Publisher Website
Google Scholar
Abstract
Showstack and colleagues (Oct. 19 issue)* have presented interesting data on the relation between the use of cyclosporine and resource consumption. There can be little doubt that cyclosporine has a beneficial effect on such outcomes as graft and patient survival after the transplantation of cadaver kidneys. In both clinical trials and secondary data sources (such as Medicare's end-stage renal disease system), patients who receive cadaver kidneys and cyclosporine consistently do better than those who do not receive cyclosporine. To the extent that cyclosporine reduces episodes of rejection and complications, the consumption of resources should also decrease.

This publication has 2 references indexed in Scilit: